{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:07:54Z","timestamp":1786118874613,"version":"build-2736575974"},"reference-count":112,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1080\/10673220802073915","type":"journal-article","created":{"date-parts":[[2008,4,15]],"date-time":"2008-04-15T23:17:03Z","timestamp":1208301423000},"page":"69-79","source":"Crossref","is-referenced-by-count":19,"title":["An Overview of Obesity in Children with Psychiatric Disorders Taking Atypical Antipsychotics"],"prefix":"10.1097","volume":"16","author":[{"given":"Lauren","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hallie","family":"Bregman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Frazier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Noyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210129","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1746-1561.2006.00067.x","article-title":"Improving the dietary patterns of adolescents using a computer-based approach.","volume":"76","author":"Casazza","year":"2006","journal-title":"J Sch Health"},{"key":"R3-2-20210129","first-page":"90","article-title":"Fasting insulin levels as a masure of insulin resistance in American blacks.","volume":"4","author":"Mack","year":"2004","journal-title":"J Appl Res"},{"key":"R4-2-20210129","first-page":"1","article-title":"Insulin resistance syndrome.","volume":"63","author":"Rao","year":"2001","journal-title":"Am Fam Physician"},{"key":"R5-2-20210129","first-page":"1047","article-title":"Hypertension in obese children: fasting serum insulin levels are closely correlated with blood pressure.","volume":"14","author":"Kanai","year":"1990","journal-title":"Int J Obes"},{"key":"R6-2-20210129","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1542\/peds.2005-0170","article-title":"Obesity, shame, and depression in school-aged children: a population-based study.","volume":"116","author":"Sjoberg","year":"2005","journal-title":"Pediatrics"},{"key":"R7-2-20210129","first-page":"387","article-title":"Mental disorders in obese children and adolescents.","volume":"66","author":"Vila","year":"2004","journal-title":"Psychosom Med"},{"key":"R8-2-20210129","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1542\/peds.113.5.1187","article-title":"Associations between overweight and obesity with bullying behaviors in school-aged children.","volume":"113","author":"Janssen","year":"2004","journal-title":"Pediatrics"},{"key":"R9-2-20210129","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4088\/JCP.v60n0402","article-title":"The distribution of body mass index among individuals with and without schizophrenia.","volume":"60","author":"Allison","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"R10-2-20210129","first-page":"303","article-title":"Obesity of mentally retarded individuals: prevalence, characteristics, and intervention.","volume":"90","author":"Burkart","year":"1985","journal-title":"Am J Ment Defic"},{"key":"R11-2-20210129","first-page":"41","article-title":"Weight change and atypical antipsychotic treatment in patients with schizophrenia.","volume":"62","author":"Jones","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R12-2-20210129","first-page":"3","article-title":"Managing health risks in psychiatric patients: practical clinical interventions.","volume":"supp","author":"Weiden","year":"2006","journal-title":"Clin Psychiatry News"},{"key":"R13-2-20210129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0306-4530(02)00110-5","article-title":"Jibson. Efficacy of newer generation antipsychotics in the treatment of schizophrenia.","volume":"29","author":"Tandon","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"R14-2-20210129","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/10401230209147399","article-title":"Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases.","volume":"14","author":"Jin","year":"2002","journal-title":"Ann Clin Psychiatry"},{"key":"R15-2-20210129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.schres.2006.08.017","article-title":"Does antipsychotic polypharmacy increase the risk for metabolic syndrome.","volume":"89","author":"Correll","year":"2007","journal-title":"Schizophr Res"},{"key":"R16-2-20210129","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis.","volume":"156","author":"Allison","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R17-2-20210129","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.chc.2005.08.007","article-title":"Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents.","volume":"15","author":"Correll","year":"2006","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"R18-2-20210129","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/104454602760219135","article-title":"Clozapine in adolescent inpatients with acute mania.","volume":"12","author":"Masi","year":"2002","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R19-2-20210129","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archpsyc.63.7.721","article-title":"Childhood-onset schizophrenia.","volume":"63","author":"Shaw","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"R20-2-20210129","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/10445460152595568","article-title":"A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder.","volume":"11","author":"Frazier","year":"2001","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R21-2-20210129","first-page":"524","article-title":"Clozapine and high dose olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison.","volume":"63","author":"Kumra","year":"2008","journal-title":"J Biopsychiatry"},{"key":"R22-2-20210129","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/sj.npp.1300327","article-title":"A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.","volume":"29","author":"Sikich","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"R23-2-20210129","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.biopsych.2005.03.019","article-title":"Open-label, 8 week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children.","volume":"56","author":"Biederman","year":"2005","journal-title":"Biol Psychiatry"},{"key":"R24-2-20210129","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1176\/appi.ajp.2007.06111932","article-title":"Olanzapine vs. placebo in the treatment of adolescents with bipolar mania.","volume":"164","author":"Tohen","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R25-2-20210129","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/cap.2004.14.405","article-title":"Quetiapine adjunctive and monotherapy for pediatric bipolar disorder: a retrospective chart review.","volume":"4","author":"Marchand","year":"2004","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R26-2-20210129","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.chi.0000194567.63289.97","article-title":"A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania.","volume":"45","author":"DelBello","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R27-2-20210129","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/cap.2005.15.311","article-title":"An open-label trial of risperidone in children and adolescents with bipolar disorder. J.","volume":"15","author":"Biederman","year":"2005","journal-title":"Child Adolesc Psychopharmacol"},{"key":"R28-2-20210129","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/chi.0b013e318040b25f","article-title":"Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials.","volume":"46","author":"Correll","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R29-2-20210129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0920-9964(02)00498-X","article-title":"Obesity as a risk factor for antipsychotic noncompliance.","volume":"66","author":"Weiden","year":"2004","journal-title":"Schizophr Res"},{"key":"R30-2-20210129","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1542\/peds.114.2.e154","article-title":"Identification, evaluation, and management of obesity in an academic primary care center.","volume":"114","author":"OBrien","year":"2004","journal-title":"Pediatrics"},{"key":"R31-2-20210129","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1547-5069.2003.00237.x","article-title":"The effects of an educational intervention on antipsychotic-induced weight gain.","volume":"35","author":"Littrell","year":"2003","journal-title":"J Nurs Scholarsh"},{"key":"R32-2-20210129","first-page":"479","article-title":"Nutritional intervention to prevent weight gain in patients commenced on olanzapine: a randomized controlled trial.","volume":"39","author":"Evans","year":"2005","journal-title":"Aus N Z J Psychiatry"},{"key":"R33-2-20210129","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1515\/JPEM.2004.17.8.1055","article-title":"Parental obesity and higher pre-intervention BMI reduce the likelihood of a multidisciplinary childhood obesity program to succeeda clinical observation.","volume":"17","author":"Eliakim","year":"2004","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R34-2-20210129","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1056-4993(18)30051-8","article-title":"Current status of family intervention science.","volume":"10","author":"Diamond","year":"2001","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"R35-2-20210129","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/adc.2005.071753","article-title":"A two-year family-based behaviour treatment for obese children.","volume":"90","author":"Jiang","year":"2005","journal-title":"Arch Dis Child"},{"key":"R36-2-20210129","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1176\/appi.ps.54.8.1155","article-title":"A program for managing weight gain associated with atypical antipsychotics.","volume":"54","author":"Vreeland","year":"2003","journal-title":"Psychiatr Serv"},{"key":"R37-2-20210129","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4088\/JCP.v65n0404","article-title":"Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program.","volume":"65","author":"Menza","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R38-2-20210129","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1542\/peds.2004-2172","article-title":"Short-and long-term beneficial effects of a combined dietary-behavioral-physical activity intervention for the treatment of childhood obesity.","volume":"115","author":"Nemet","year":"2005","journal-title":"Pediatrics"},{"key":"R39-2-20210129","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4088\/JCP.v64n0808","article-title":"Reversal of antipsychotic-associated weight gain.","volume":"64","author":"OKeefe","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R40-2-20210129","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.schres.2006.01.008","article-title":"A Cognitivebehavioral group intervention for weight loss in patients treated with atypical antipsychotics.","volume":"83","author":"Weber","year":"2006","journal-title":"Schizophr Res"},{"key":"R41-2-20210129","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1034\/j.1600-0447.2003.00190.x","article-title":"Behavioral management of antipsychotic-induced weight gain: a review.","volume":"108","author":"Werneke","year":"2003","journal-title":"Acta Psychiatr Scand"},{"key":"R42-2-20210129","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1034\/j.1600-0447.2003.00218.x","article-title":"Schizophrenia and weight management: a systematic review of interventions to control weight.","volume":"108","author":"Faulkner","year":"2003","journal-title":"Acta Psychiatr Scand"},{"key":"R43-2-20210129","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.4088\/JCP.v66n0815","article-title":"Behavioral treatment of obesity in patients taking antipsychotic medications.","volume":"66","author":"Kalarchian","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R44-2-20210129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4088\/JCP.v66n0208","article-title":"Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder.","volume":"66","author":"Brar","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R45-2-20210129","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/jpepsy\/jsh054","article-title":"Inpatient treatment for children with obesity: weight loss, psychological well-being, and eating behavior.","volume":"29","author":"Braet","year":"2004","journal-title":"J Pediatr Psychol"},{"key":"R46-2-20210129","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/archpedi.159.10.963","article-title":"Improvement of fitness, body composition, and insulin sensitivity in overweight children in a school-based exercise program.","volume":"259","author":"Carrell","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R47-2-20210129","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1001\/jama.295.13.1539","article-title":"Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals.","volume":"295","author":"Heilbronn","year":"2006","journal-title":"J Am Med Assoc"},{"key":"R48-2-20210129","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4088\/JCP.v62n0208","article-title":"Weight gain with risperidone among patients with mental retardation: effect of calorie restriction.","volume":"62","author":"Cohen","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R49-2-20210129","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/oby.2001.134","article-title":"Very-low-calorie diets and sustained weight loss.","volume":"9","author":"Saris","year":"2001","journal-title":"Obes Res"},{"key":"R50-2-20210129","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0031-3955(05)70356-4","article-title":"Intensive therapies for pediatric obesity.","volume":"48","author":"Yanovski","year":"2001","journal-title":"Pediatr Clin North Am"},{"key":"R51-2-20210129","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/jama.295.7.826","article-title":"Obesity researchlimitations of methods, measurements, and medications.","volume":"295","author":"Simons-Morton","year":"2006","journal-title":"JAMA"},{"key":"R52-2-20210129","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/01.mop.0000170515.35272.9e","article-title":"Current treatment approaches to overweight in adolescents.","volume":"17","author":"Durant","year":"2005","journal-title":"Curr Opin Pediatr"},{"key":"R53-2-20210129","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.schres.2003.09.016","article-title":"Weight decline in patients switching from olanzapine to quetiapine.","volume":"70","author":"Gupta","year":"2003","journal-title":"Schizophr Res"},{"key":"R54-2-20210129","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00213-004-1951-2","article-title":"Weight loss after switching from conventional olanzapine tablets to orally disintegrating olanzapine tablets.","volume":"175","author":"Haan","year":"2004","journal-title":"Psychopharmacology"},{"key":"R55-2-20210129","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/00128072-200103060-00001","article-title":"Pharmacological treatment of obesity in pediatric patients.","volume":"3","author":"Daniels","year":"2001","journal-title":"Pediatr Drugs"},{"key":"R56-2-20210129","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/sj.ijo.0803084","article-title":"New drug policy in childhood obesity.","volume":"29","author":"Molnar","year":"2005","journal-title":"Int J Obes"},{"key":"R57-2-20210129","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2165\/00003495-200666120-00012","article-title":"Orlistat: a review of its use in the management of obesity.","volume":"66","author":"Henness","year":"2006","journal-title":"Drugs"},{"key":"R58-2-20210129","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1463-1326.2002.00237.x","article-title":"The effects of orlistat on body weight and glycemic control in overweight patients with type 2 diabetes: a randomized, placebo-controlled trial.","volume":"4","author":"Hanefeld","year":"2002","journal-title":"Diabetes Obes Metab"},{"key":"R59-2-20210129","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/sj.ijo.0801814","article-title":"The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled multicenter study.","volume":"25","author":"Muls","year":"2001","journal-title":"Int J Obes"},{"key":"R60-2-20210129","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1463-1326.2003.00262.x","article-title":"Latin-American trial of orlistat for weight loss and improvement in glycemic profile in obese diabetic patients.","volume":"5","author":"Halpern","year":"2003","journal-title":"Diabetes Obes Metab"},{"key":"R61-2-20210129","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/sj.ijo.0802281","article-title":"Weight reduction and long-term maintenance after 18-month treatment with orlistat for obesity.","volume":"27","author":"Krempf","year":"2003","journal-title":"Int J Obes"},{"key":"R62-2-20210129","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1463-1326.2005.00483.x","article-title":"Weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.","volume":"7","author":"Toplak","year":"2005","journal-title":"Diabetes Obes Metab"},{"key":"R63-2-20210129","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1365-2036.2004.01966.x","article-title":"Cholesterol lowering effect of dietary weight loss and orlistat treatmentefficacy and limitations.","volume":"19","author":"Erdmann","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"R64-2-20210129","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1001\/jama.293.23.2873","article-title":"Effect of orlistat on weight and body composition in obese adolescents.","volume":"293","author":"Chanoine","year":"2005","journal-title":"JAMA"},{"key":"R65-2-20210129","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1515\/JPEM.2004.17.3.307","article-title":"Efficacy of orlistat as an adjunct to behavioral treatment in overweight African-American and Caucasian adolescents with obesity-related co-morbid conditions.","volume":"17","author":"McDuffie","year":"2004","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R66-2-20210129","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/oby.2002.87","article-title":"Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions.","volume":"10","author":"McDuffie","year":"2002","journal-title":"Obes Res"},{"key":"R67-2-20210129","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4158\/EP.12.1.18","article-title":"Randomized, double-blind, placebo-controlled trial of orlistat for weight loss in adolescents.","volume":"12","author":"Maahs","year":"2006","journal-title":"Endocr Pract"},{"key":"R68-2-20210129","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1517\/14656566.5.3.633","article-title":"Sibutramine and the management of obesity.","volume":"5","author":"Poston","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"R69-2-20210129","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1210\/jc.2004-0263","article-title":"Treatment of obese adolescents with sibutramine: a randomized, double-blind, controlled study.","volume":"90","author":"Godoy-Matos","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R70-2-20210129","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.clinthera.2006.05.008","article-title":"Use of sibutramine in obese Mexican adolescents: a month, randomized, double-blind, placebo-controlled parellel-group trial.","volume":"28","author":"Garcia-Morales","year":"2006","journal-title":"Clin Ther"},{"key":"R71-2-20210129","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/BF02849958","article-title":"Use of sibutramine in obese Hispanic adolescents.","volume":"22","author":"Violante-Ortiz","year":"2005","journal-title":"Adv Ther"},{"key":"R72-2-20210129","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1001\/jama.289.14.1805","article-title":"Behavior therapy and sibutramine for the treatment of adolescent obesity.","volume":"289","author":"Berkowitz","year":"2003","journal-title":"JAMA"},{"key":"R73-2-20210129","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1067\/mhj.2001.117510","article-title":"Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia.","volume":"142","author":"Dujovne","year":"2001","journal-title":"Am Heart J"},{"key":"R74-2-20210129","first-page":"30","article-title":"Sibutramine as an adjuvant therapy in adolescents suffering from morbid besity.","volume":"8","author":"Reisler","year":"2006","journal-title":"Isr Med Assoc J"},{"key":"R75-2-20210129","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/sj.ijo.0801592","article-title":"Second phase of a double-blind study clinical trial on sibutramine for the treatment of patients suffering essential obesity: 6 months after treatment cross-over.","volume":"25","author":"Fanghanel","year":"2001","journal-title":"Int J Obes"},{"key":"R76-2-20210129","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1176\/appi.ajp.162.5.954","article-title":"A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain.","volume":"162","author":"Henderson","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R77-2-20210129","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/adc.2006.098962","article-title":"Should metformin be prescribed to overweight adolescents in whom dietarybehavioural modifications have not helped.","volume":"91","author":"Webb","year":"2006","journal-title":"Arch Dis Child"},{"key":"R78-2-20210129","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archpedi.160.3.241","article-title":"Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome.","volume":"160","author":"Bridger","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R79-2-20210129","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1515\/JPEM.2006.19.6.831","article-title":"Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome.","volume":"19","author":"Glueck","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R80-2-20210129","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/diacare.25.1.89","article-title":"Effect of metformin in pediatric patients with type 2 diabetes.","volume":"25","author":"Jones","year":"2002","journal-title":"Diabetes Care"},{"key":"R81-2-20210129","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2362.1998.00304.x","article-title":"Effect of metformin on food intake in obese subjects.","volume":"28","author":"Paolisso","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"R82-2-20210129","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1210\/jc.2006-0241","article-title":"Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin.","volume":"91","author":"Srinivasan","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R83-2-20210129","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1053\/meta.2001.28078","article-title":"Beneficial effects of metformin in normoglycemic morbidly obese adolescents.","volume":"50","author":"Kay","year":"2001","journal-title":"Metabolism"},{"key":"R84-2-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.107.4.e55","article-title":"The effect of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.","volume":"107","author":"Freemark","year":"2001","journal-title":"Pediatrics"},{"key":"R85-2-20210129","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1176\/appi.ajp.159.4.655","article-title":"Metformin for weight loss in pediatric patients taking psychotropic drugs.","volume":"159","author":"Morrison","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R86-2-20210129","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1176\/ajp.2006.163.12.2072","article-title":"A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.","volume":"163","author":"Klein","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R87-2-20210129","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/oby.2003.102","article-title":"A 6 month randomized, placebo-controlled dose-ranging trial of topiramate for weight loss in obesity.","volume":"11","author":"Bray","year":"2003","journal-title":"Obes Res"},{"key":"R88-2-20210129","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.jcp.0000162806.46453.38","article-title":"Influence of topiramate on olanzapine-related adiposity in women.","volume":"25","author":"Nickel","year":"2005","journal-title":"J Clin Psychopharmachol"},{"key":"R89-2-20210129","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/01.jcp.0000130556.01373.45","article-title":"Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder.","volume":"24","author":"Vieta","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"R90-2-20210129","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1440-1819.2005.01424.x","article-title":"Management of atypical antipsychotic-induced weight gain in schizophrenic patients with topiramate.","volume":"59","author":"Lin","year":"2005","journal-title":"Psychiatry Clin Neurosci"},{"key":"R91-2-20210129","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.braindev.2004.06.006","article-title":"Cllinical Experience with topiramate to counteract neuroleptic-induced weight gain in 10 individuals with autistic spectrum disorders.","volume":"27","author":"Canitano","year":"2005","journal-title":"Brain Dev"},{"key":"R92-2-20210129","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1176\/appi.ajp.162.9.1744","article-title":"Double-blind, placebo-controlled investigation of amantadine for weight loss in subjects who gained weight with oanzapine.","volume":"162","author":"Graham","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R93-2-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.euroneuro.2004.03.005","article-title":"Amantadine for weight gain associated with olanzapine treatment.","volume":"15","author":"Deberdt","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"R94-2-20210129","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/104454602760386941","article-title":"Amantadine treatment of psychotropic-induced weight gain in children and adolescents: case series.","volume":"12","author":"Gracious","year":"2002","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R95-2-20210129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1440-1819.2003.01211.x","article-title":"Open-label study of the effect of amantadine on weight gain induced by olanzapine.","volume":"58","author":"Bahk","year":"2004","journal-title":"Psychiatry Clin Neurosci"},{"key":"R96-2-20210129","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0006-3223(98)00186-3","article-title":"Hypothalamic serotonin in control of eating behavior, meal size, and body weight.","volume":"44","author":"Leibowitz","year":"1998","journal-title":"Biol Psychiatry"},{"key":"R97-2-20210129","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/10401230590932407","article-title":"Modafinil-associated weight loss in a clozapine-treated schizoaffective disorder patient.","volume":"17","author":"Henderson","year":"2005","journal-title":"Ann Clin Psychiatry"},{"key":"R98-2-20210129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.appet.2003.11.003","article-title":"Wake-promoting agents with different mechanisms of action: comparison of effects of modafinil and amphetamine on food intake and cardiovascular activity.","volume":"42","author":"Makris","year":"2004","journal-title":"Appetite"},{"key":"R99-2-20210129","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/01.chi.0000205709.63571.c9","article-title":"A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficithyperactivity disorder.","volume":"45","author":"Greenhill","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R100-2-20210129","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00004850-200503000-00007","article-title":"The effects of betahistine, a histamine H1 receptor agonistH3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenic patients.","volume":"20","author":"Poyurovsky","year":"2005","journal-title":"Int Clin Psychopharmacol"},{"key":"R101-2-20210129","first-page":"85","article-title":"Randomized, open-label study on the use of ranitidine at different doses for the management of weight gain associated with olanzapine administration.","volume":"14","author":"Lopez-Mato","year":"2003","journal-title":"Vertex"},{"key":"R102-2-20210129","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.289.14.1826","article-title":"Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults.","volume":"289","author":"Ettinger","year":"2003","journal-title":"JAMA"},{"key":"R103-2-20210129","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1651-2227.2003.tb00596.x","article-title":"Orlistat treatment in obese prepubertal children: a pilot study.","volume":"92","author":"Norgren","year":"2003","journal-title":"Acta Pediatr"},{"key":"R104-2-20210129","doi-asserted-by":"crossref","first-page":"602","DOI":"10.2337\/diacare.24.3.602","article-title":"Diabetic ketoacidosis associated with orlistat treatment.","volume":"25","author":"Azar","year":"2001","journal-title":"Diabetes Care"},{"key":"R105-2-20210129","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s10286-005-0270-y","article-title":"Paradoxical effect of sibutramine on autonomic cardiovascular regulation in obese hypertensive patients.","volume":"15","author":"Birkenfeld","year":"2005","journal-title":"Clin Auton Res"},{"key":"R106-2-20210129","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/sj.ijo.0802887","article-title":"Influence of sibutramine on blood pressure: evidence from placebo-controlled trials.","volume":"29","author":"Jordan","year":"2005","journal-title":"Int J Obes"},{"key":"R107-2-20210129","first-page":"283","article-title":"Sibutramine-induced mania episode in a bipolar patient.","volume":"5","author":"Cordeiro Vallada","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"R108-2-20210129","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1176\/ajp.2006.163.12.2034","article-title":"Gaining: pediatric patients and use of atypical antipsychotics.","volume":"163","author":"Towbin","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R109-2-20210129","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00431-005-1634-y","article-title":"Severe metformin intoxication with lactic acidosis in an adolescent.","volume":"164","author":"Lacher","year":"2005","journal-title":"Eur J Pediatr"},{"key":"R110-2-20210129","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1212\/01.wnl.0000238099.36998.6b","article-title":"Effect of topiramate on cognition in obese children.","volume":"1","author":"Aarsen","year":"2006","journal-title":"Neurology"},{"key":"R111-2-20210129","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.chi.0000220851.94392.30","article-title":"Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents.","volume":"45","author":"Correll","year":"2006","journal-title":"J Am Acad Child Adolsec Psychiatry"},{"key":"R112-2-20210129","first-page":"2643","article-title":"Confronting the epidemic of childhood obesity.","volume":"292","author":"Caprio","year":"2004","journal-title":"JAMA"},{"key":"R113-2-20210129","first-page":"596","article-title":"Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes.","volume":"27","year":"2004","journal-title":"Diabetes Care"}],"container-title":["Harvard Review of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00023727-200803000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:00:54Z","timestamp":1786035654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00023727-200803000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":112,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1080\/10673220802073915","relation":{},"ISSN":["1067-3229"],"issn-type":[{"value":"1067-3229","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}